Home » US FDA Overseas Offices Should Improve Coordination, Planning for Import Safety
US FDA Overseas Offices Should Improve Coordination, Planning for Import Safety
November 17, 2010
Better coordination between the U.S. Food and Drug Administration’s (FDA) overseas offices and their domestic counterparts as well as long-term strategic planning is needed to improve the role of those offices in the face of the growing challenge of import safety, according to the U.S. Government Accountability Office (GAO).
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor